The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantation

J. Ludwig, R. H. Wiesner, K. P. Batts, J. D. Perkins, R. A. Krom

Research output: Contribution to journalArticle

163 Citations (Scopus)

Abstract

The acute vanishing bile duct syndrome can be defined as an irreversible, rejection-related condition that affects hepatic allografts within 100 days after orthotopic liver transplantation and whose presence requires retransplantation. We have observed the acute vanishing bile duct syndrome in 5 of 48 consecutive patients (approximately 10%) who underwent orthotopic liver transplantation. In 4 cases, the condition progressed relentlessly within approximately 7 to 11 weeks after orthotopic liver transplantation from mild rejection to severe rejection to acute vanishing bile duct syndrome. A fifth patient had severe rejection in the first week and required retransplantation after 17 days because of thrombotic venoocclusive disease complicating the acute vanishing bile duct syndrome. Clinically, signs of impending acute vanishing bile duct syndrome included abrupt onset of fever and jaundice and marked elevation of serum bilirubin and alkaline phosphatase levels which persisted despite antirejection treatment. Biopsy specimens revealed destructive cholangitis (rejection cholangitis), ductopenia, and, if retranspslantation was delayed, presence of noninflammatory, 'burnt-out' portal tracts without bile ducts. We recommend to base the diagnosis of acute vanishing bile duct syndrome on documentation of severe ductopenia in at least 20 portal tracts which may require several consecutive needle biopsies. Rejection arteriopathy which was found in 3 of our 5 cases might have been another important diagnostic clue but could not be recognized prior to retransplantation. The pathogenesis of acute vanishing bile duct syndrome is not clear; until the condition had manifested itself, we found no qualitative differences between acute reversible and irreversible rejection. After retransplantation, severe rejection has recurred in the four patients who could be evaluated in this regard; one of these patients already needed a second retransplantation for vanishing bile duct syndrome.

Original languageEnglish (US)
Pages (from-to)476-483
Number of pages8
JournalHepatology
Volume7
Issue number3
DOIs
StatePublished - 1987

Fingerprint

Bile Ducts
Liver Transplantation
Cholangitis
Graft Rejection
Needle Biopsy
Acute Disease
Jaundice
Bilirubin
Documentation
Allografts
Alkaline Phosphatase
Fever
Biopsy
Liver
Serum

ASJC Scopus subject areas

  • Hepatology

Cite this

The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantation. / Ludwig, J.; Wiesner, R. H.; Batts, K. P.; Perkins, J. D.; Krom, R. A.

In: Hepatology, Vol. 7, No. 3, 1987, p. 476-483.

Research output: Contribution to journalArticle

Ludwig, J. ; Wiesner, R. H. ; Batts, K. P. ; Perkins, J. D. ; Krom, R. A. / The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantation. In: Hepatology. 1987 ; Vol. 7, No. 3. pp. 476-483.
@article{aea732a43e674edb9cbcf3da3c9bf0f2,
title = "The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantation",
abstract = "The acute vanishing bile duct syndrome can be defined as an irreversible, rejection-related condition that affects hepatic allografts within 100 days after orthotopic liver transplantation and whose presence requires retransplantation. We have observed the acute vanishing bile duct syndrome in 5 of 48 consecutive patients (approximately 10{\%}) who underwent orthotopic liver transplantation. In 4 cases, the condition progressed relentlessly within approximately 7 to 11 weeks after orthotopic liver transplantation from mild rejection to severe rejection to acute vanishing bile duct syndrome. A fifth patient had severe rejection in the first week and required retransplantation after 17 days because of thrombotic venoocclusive disease complicating the acute vanishing bile duct syndrome. Clinically, signs of impending acute vanishing bile duct syndrome included abrupt onset of fever and jaundice and marked elevation of serum bilirubin and alkaline phosphatase levels which persisted despite antirejection treatment. Biopsy specimens revealed destructive cholangitis (rejection cholangitis), ductopenia, and, if retranspslantation was delayed, presence of noninflammatory, 'burnt-out' portal tracts without bile ducts. We recommend to base the diagnosis of acute vanishing bile duct syndrome on documentation of severe ductopenia in at least 20 portal tracts which may require several consecutive needle biopsies. Rejection arteriopathy which was found in 3 of our 5 cases might have been another important diagnostic clue but could not be recognized prior to retransplantation. The pathogenesis of acute vanishing bile duct syndrome is not clear; until the condition had manifested itself, we found no qualitative differences between acute reversible and irreversible rejection. After retransplantation, severe rejection has recurred in the four patients who could be evaluated in this regard; one of these patients already needed a second retransplantation for vanishing bile duct syndrome.",
author = "J. Ludwig and Wiesner, {R. H.} and Batts, {K. P.} and Perkins, {J. D.} and Krom, {R. A.}",
year = "1987",
doi = "10.1002/hep.1840070311",
language = "English (US)",
volume = "7",
pages = "476--483",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

TY - JOUR

T1 - The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantation

AU - Ludwig, J.

AU - Wiesner, R. H.

AU - Batts, K. P.

AU - Perkins, J. D.

AU - Krom, R. A.

PY - 1987

Y1 - 1987

N2 - The acute vanishing bile duct syndrome can be defined as an irreversible, rejection-related condition that affects hepatic allografts within 100 days after orthotopic liver transplantation and whose presence requires retransplantation. We have observed the acute vanishing bile duct syndrome in 5 of 48 consecutive patients (approximately 10%) who underwent orthotopic liver transplantation. In 4 cases, the condition progressed relentlessly within approximately 7 to 11 weeks after orthotopic liver transplantation from mild rejection to severe rejection to acute vanishing bile duct syndrome. A fifth patient had severe rejection in the first week and required retransplantation after 17 days because of thrombotic venoocclusive disease complicating the acute vanishing bile duct syndrome. Clinically, signs of impending acute vanishing bile duct syndrome included abrupt onset of fever and jaundice and marked elevation of serum bilirubin and alkaline phosphatase levels which persisted despite antirejection treatment. Biopsy specimens revealed destructive cholangitis (rejection cholangitis), ductopenia, and, if retranspslantation was delayed, presence of noninflammatory, 'burnt-out' portal tracts without bile ducts. We recommend to base the diagnosis of acute vanishing bile duct syndrome on documentation of severe ductopenia in at least 20 portal tracts which may require several consecutive needle biopsies. Rejection arteriopathy which was found in 3 of our 5 cases might have been another important diagnostic clue but could not be recognized prior to retransplantation. The pathogenesis of acute vanishing bile duct syndrome is not clear; until the condition had manifested itself, we found no qualitative differences between acute reversible and irreversible rejection. After retransplantation, severe rejection has recurred in the four patients who could be evaluated in this regard; one of these patients already needed a second retransplantation for vanishing bile duct syndrome.

AB - The acute vanishing bile duct syndrome can be defined as an irreversible, rejection-related condition that affects hepatic allografts within 100 days after orthotopic liver transplantation and whose presence requires retransplantation. We have observed the acute vanishing bile duct syndrome in 5 of 48 consecutive patients (approximately 10%) who underwent orthotopic liver transplantation. In 4 cases, the condition progressed relentlessly within approximately 7 to 11 weeks after orthotopic liver transplantation from mild rejection to severe rejection to acute vanishing bile duct syndrome. A fifth patient had severe rejection in the first week and required retransplantation after 17 days because of thrombotic venoocclusive disease complicating the acute vanishing bile duct syndrome. Clinically, signs of impending acute vanishing bile duct syndrome included abrupt onset of fever and jaundice and marked elevation of serum bilirubin and alkaline phosphatase levels which persisted despite antirejection treatment. Biopsy specimens revealed destructive cholangitis (rejection cholangitis), ductopenia, and, if retranspslantation was delayed, presence of noninflammatory, 'burnt-out' portal tracts without bile ducts. We recommend to base the diagnosis of acute vanishing bile duct syndrome on documentation of severe ductopenia in at least 20 portal tracts which may require several consecutive needle biopsies. Rejection arteriopathy which was found in 3 of our 5 cases might have been another important diagnostic clue but could not be recognized prior to retransplantation. The pathogenesis of acute vanishing bile duct syndrome is not clear; until the condition had manifested itself, we found no qualitative differences between acute reversible and irreversible rejection. After retransplantation, severe rejection has recurred in the four patients who could be evaluated in this regard; one of these patients already needed a second retransplantation for vanishing bile duct syndrome.

UR - http://www.scopus.com/inward/record.url?scp=0023179735&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023179735&partnerID=8YFLogxK

U2 - 10.1002/hep.1840070311

DO - 10.1002/hep.1840070311

M3 - Article

C2 - 3552923

AN - SCOPUS:0023179735

VL - 7

SP - 476

EP - 483

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 3

ER -